The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABIVAX SA SPONSORED ADS 00370M103   6,540,737 48,502 SH   SOLE   3,593 0 44,909
ARGENX SE SPONSORED ADR 04016X101   30,009,301 35,685 SH   SOLE   2,700 0 32,985
BIONTECH SE SPONSORED ADS 09075V102   35,339,763 371,216 SH   SOLE   27,452 0 343,764
CG ONCOLOGY INC COM 156944100   6,726,448 162,005 SH   SOLE   12,274 0 149,731
ELI LILLY & CO COM 532457108   8,927,367 8,307 SH   SOLE   612 0 7,695
IONIS PHARMACEUTICALS INC COM 462222100   18,865,915 238,477 SH   SOLE   17,548 0 220,929
LEGEND BIOTECH CORP SPONSORED ADS 52490G102   22,971,962 1,056,668 SH   SOLE   78,958 0 977,710
MINERALYS THERAPEUTICS INC COM 603170101   7,644,416 210,648 SH   SOLE   15,508 0 195,140
NATERA INC COM 632307104   18,017,929 78,650 SH   SOLE   5,787 0 72,863
PFIZER INC COM 717081103   50,851,826 2,042,242 SH   SOLE   154,834 0 1,887,408
REGENERON PHARMACEUTICALS COM 75886F107   40,461,425 52,420 SH   SOLE   3,988 0 48,432
ROIVANT SCIENCES LTD SHS G76279101   22,314,067 1,028,298 SH   SOLE   78,179 0 950,119
ROYALTY PHARMA PLC SHS CLASS A G7709Q104   32,482,716 840,650 SH   SOLE   63,877 0 776,773
VIRIDIAN THERAPEUTICS INC COM 92790C104   8,141,459 261,615 SH   SOLE   19,256 0 242,359